A substantial advancement in diabetes management is emerging with the approval of tirzepatide in a 45mg form. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, and https://hassanpeyc707398.mywikiparty.com/2300024/groundbreaking_development_tirzepatide_45mg_for_diabetes_management